by DiaCarta Inc. | Apr 17, 2015 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ April ❯ DiaCarta Obtains Exclusive License for Non-Invasive Early Detection Colon Cancer Test FollowFollow DIACARTA INC. (“DIACARTA”) and UNIVERSITY OF POTSDAM (Germany) today...
by DiaCarta Inc. | Jan 9, 2015 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ January ❯ DiaCarta, Inc Closes $8 Million Series A Round for Development and Commercialization of Precision Molecular Diagnostics FollowFollow DiaCarta, Inc is a privately-held...
by DiaCarta Inc. | Feb 26, 2014 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ February ❯ DiaCarta Inc. Receives CE Mark for Its Proprietary IVD Cancer Mutation Tests: KRAS, NRAS, EGFR and More FollowFollow DiaCarta, a technology-driven translational genomics and...
by DiaCarta Inc. | Oct 28, 2013 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ October ❯ DiaCarta Inc. Launches QClamp™ Somatic Mutation Real-Time PCR Tests for KRAS, NRAS, EGFR, BRAF, PIK3CA and More Without DNA Extractions FollowFollow DiaCarta is a new...
